|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Blood Coagulation Disorders | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hemostatic Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Vascular Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Human Genome Research Institute (NHGRI) | |||||